Showing the effects of comorbidity of Diabetes Mellitus on diabetics’ population from a simple linear mathematical model
*Victor Olajide AkinsolaCorresponding authorakinsolaolajide@adelekeuniversity.edu.ngsolajide123@gmail.comComputational LaboratoryDepartment of Mathematics, P. M. B. 250Adeleke UniversityOsun State, 232103, NigeriaView full profile → , Temitayo Olubisi Oluyotooluyo@lautech.edu.ngDepartment of Pure and Applied MathematicsP. M. B. 4000Ladoke Akintola University of TechnologyOgbomoso, NigeriaView full profile → , Adeyemi Olukayode Binuyobinuyok@gmail.comDepartment of Mathematical SciencesAjayi Crowther UniversityOyo, NigeriaView full profile → , David Ifeoluwa Oladapooladapo.ifeoluwa@adelekeuniversity.edu.ngDepartment of MathematicsEdeAdeleke UniversityOsun State, NigeriaView full profile →
* Corresponding author · click or hover a name for details
- Received:
- 05 Oct 2021
- Accepted:
- 13 May 2022
- Published Online:
- 15 Jan 2025
- Article type:
- Research Article
- Language:
- EN
- Article no.:
- JSMS-970
- Pages:
- 47–65
Abstract
Keywords
Subject Classifications
References
[1] A. Ludington and H. Diehl, Health Power: Health by Choice, Not Chance, Review and Herald Publishing Association, Hagerstown, USA (2000).
[2] R. K. Murray, D. A. Bender, K. M. Botham, V. W. Rodwell, and P. A. Weil, Harper’s Illustrated Biochemistry, 29th ed., McGraw-Hill, New York (2012).
[3] International Diabetes Federation, IDF Diabetes Atlas, 9th ed., Brussels, Belgium (2019). [Online]. Available: https://diabetesatlas.org/idfawp/resourcefiles/2019/07/IDF_diabetes_atlas_ninth_edition_en.pdf.
[4] J. D. Piette and E. A. Kerr, “The impact of comorbid chronic conditions on diabetes care,” Diabetes Care, vol. 29, no. 3, pp. 725–731 (2006).
[5] A. N. Long and S. Dagogo-Jack, “Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection,” The J. Clin. Hypertension, vol. 13, no. 4, pp. 244–251 (2011). doi: 10.1111/j.1751-7176.2011.00434.x.
[6] M. J. Knol, J. W. R. Twisk, A. T. F. Beekman, R. J. Heine, F. J. Snoek, and F. Pouwer, “Depression as a risk factor for the onset of type 2 diabetes mellitus: A meta-analysis,” Diabetologia, vol. 49, pp. 837–845 (2006).
[7] K. K. Tsilidis, J. C. Kasimis, D. S. Lopez, E. E. Ntzani, and J. P. Ioannidis, “Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies,” BMJ, vol. 350, g7607 (2015). doi: 10.1136/bmj.g7607.
[8] Australian Institute of Health and Welfare, “Diabetes and disability: impairments, activity limitations, participation restrictions and comorbidities,” Diabetes Series No. 20, Cat. No. CVD 63, Canberra (2013).
[9] E. Metta, A. Bailey, F. Kessy, E. Geubbels, and H. Haisma, “Illness experiences of diabetes in the context of malaria in settings experiencing double burden of disease in south-eastern Tanzania,” PLoS ONE, vol. 12, no. 5 (2017). [Online]. Available: https://doi.org/10.1371/journal.pone.0178394.
[10] L. Zhu, Z. G. She, X. Cheng, J. J. Qin, and X. J. Zhang, “Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes,” Cell Metab. (2020). [Online]. Available: https://www.sciencedirect.com/science/article/pii/S1550413120302382.
[11] A. Sanyaolu, C. Okorie, A. Marinkovic, R. Patidar, K. Younis, P. Desai, Z. Hosein, I. Padda, J. Mangat, and M. Altaf, “Comorbidity and its impact on patients with COVID-19,” Springer Nature Comprehensive Clinical Medicine, vol. 2, pp. 1069–1076 (2020). [Online]. Available: https://doi.org/10.1007/s42399-020-00363-4.
[12] B. Wang, R. Li, Z. Lu, and Y. Huang, “Does comorbidity increase the risk of patients with COVID-19: Evidence from meta-analysis,” Aging, vol. 12, no. 7, pp. 6049–6057 (2020). [Online]. Available: https://doi.org/10.18632/aging.103000.
[13] C. Sardu, J. Gambardella, M. B. Morelli, X. Wang, R. Marfella, and G. Santulli, “Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence,” J. Clin. Med. Res., vol. 9, no. 5, p. 1417 (2020). doi: 10.3390/jcm9051417.
[14] A. Remuzzi and G. Remuzzi, “COVID-19 and Italy: what next?” Lancet, vol. 395, pp. 1225–1228 (2020). doi: 10.1016/s0140-6736(20)30627-30629.
[15] W.-j. Guan, W.-h. Liang, Y. Zhao, H.-r. Liang, Z.-s. Chen, Y.-m. Li, X.-q. Liu, R.-c. Chen, C.-l. Tang, T. Wang, C.-q. Ou, L. Li, P.-y. Chen, L. Wang, Y. Li, Y.-h. Hu, L.-h. Shan, C.-l. Lei, Y.-x. Peng, L.-y. Wei, Y.-q. Zhao, J.-f. Li, Z.-y. Ni, J.-x. Xiang, Y. Hu, L. Liu, H. Shan, C.-l. Lei, Y.-x. Peng, W.-l. Liu, J.-m. Wang, Z.-h. Liu, J.-x. Chen, Z.-h. Li, Z.-j. Zheng, S.-q. Qiu, J.-e. Luo, C.-j. Ye, S.-y. Zhu, L.-l. Cheng, F.-j. Ye, S.-y. Li, J.-p. Zheng, N.-f. Zhang, N.-s. Zhong, and J.-x. He, “Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis,” Eur. Respir. J., vol. 55, no. 5 (2020). [Online]. Available: https://doi.org/10.1183/13993003.00547-2020.
[16] A. Boutayeb, E. H. Twizell, K. Achouayb, and A. Chetouani, “A mathematics model for the burden of diabetes and its complications,” BioMedical Engineering Online, vol. 3, p. 20 (2004). [Online]. Available: www.biomedical-engineering-online.com.
[17] I. I. Adamu, Y. Haruna, and E. J. D. Garba, “A mathematical model for attenuating the spread of diabetes and its management in a population,” Global J. Mathematical Sci., vol. 11, no. 1–2, pp. 1–14 (2012).
[18] V. O. Akinsola and T. O. Oluyo, “Mathematical model of the complications and control of diabetes mellitus,” Int. J. Math. Comput. Appl. Res., vol. 4, no. 5, pp. 1–14 (2014). [Online]. Available: www.tjprc.org.
[19] V. O. Akinsola and T. O. Oluyo, “A note on the divergence of the numerical solution of the mathematical model for the burden of diabetes and its complications using Euler method,” Int. J. Math. Comput. Appl. Res., vol. 5, no. 3, pp. 93–100 (2015). [Online]. Available: www.tjprc.org.
[20] V. O. Akinsola and T. O. Oluyo, “Mathematical analysis with numerical solutions of the mathematical model for the complication and control of diabetes mellitus,” J. Stat. Manag. Sci., vol. 22, no. 5, pp. 845–869 (2019). [Online]. Available: https://doi.org/10.1080/09720510.2018.1556409.
[21] V. O. Akinsola and T. O. Oluyo, “Analytic solution of mathematical model of the complications and control of diabetes mellitus using fundamental matrix method,” J. Interdiscip. Math., vol. 23, no. 4, pp. 877–884 (2020). [Online]. Available: https://doi.org/10.1080/09720502.2020.1727615.
[22] D. Yong, C. Heidemann, A. Gößwald, P. Schmich, and C. Scheidt-Nave, “Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany—results of the national telephone health interview survey ‘German Health Update (GEDA) 2009’,” BMC Public Health, vol. 13, p. 166 (2013). [Online]. Available: http://www.biomedcentral.com/1471-2458/13/166.
[23] Australian Institute of Health and Welfare, “Diabetes and disability: impairments, activity limitations, participation restrictions and comorbidities,” Diabetes Series No. 20, Cat. No. CVD 63, Canberra (2013).
[24] S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes, estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053 (2004).
